The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
B-Type Natriuretic Peptide–Guided Heart Failure Therapy: A Meta-analysis
Abstract
BACKGROUND: The use of plasma levels of B-type natriuretic peptides (BNPs) to guide treatment of patients with chronic heart failure (HF) has been investigated in a number of randomized controlled trials (RCTs). However, the benefits of this treatment approach have been uncertain. We therefore performed a meta-analysis to examine the overall effect of BNP-guided drug therapy on cardiovascular outcomes in patients with chronic HF. METHODS: We identified RCTs by systematic search of manuscripts, abstracts, and databases. Eligible RCTs were those that enrolled more than 20 patients and involved comparison of BNP-guided drug therapy vs usual clinical care of the patient with chronic HF in an outpatient setting. RESULTS: Eight RCTs with a total of 1726 patients and with a mean duration of 16 months (range, 3-24 months) were included in the meta-analysis. Overall, there was a significantly lower risk of all-cause mortality (relative risk [RR], 0.76; 95% confidence interval [CI], 0.63-0.91; P = .003) in the BNP-guided therapy group compared with the control group. In the subgroup of patients younger than 75 years, all-cause mortality was also significantly lower in the BNP-guided group (RR, 0.52; 95% CI, 0.33-0.82; P = .005). However, there was no reduction in mortality with BNP-guided therapy in patients 75 years or older (RR, 0.94; 95% CI, 0.71-1.25; P = .70). The risk of all-cause hospitalization and survival free of any hospitalization was not significantly different between groups (RR, 0.82; 95% CI, 0.64-1.05; P = .12 and RR, 1.07; 95% CI, 0.85-1.34; P = .58, respectively). The additional percentage of patients achieving target doses of angiotensin-converting enzyme inhibitors and beta-blockers during the course of these trials averaged 21% and 22% in the BNP group and 11.7% and 12.5% in the control group, respectively. CONCLUSIONS: B-type natriuretic peptide-guided therapy reduces all-cause mortality in patients with chronic HF compared with usual clinical care, especially in patients younger than 75 years. A component of this survival benefit may be due to increased use of agents proven to decrease mortality in chronic HF. However, there does not seem to be a reduction in all-cause hospitalization or an increase in survival free of hospitalization using this approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Dickstein, K., Authors/Task Force Members, Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.005 · Cited by 3,512
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Authors/Task Force Members, Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn309 · Cited by 2,696
Hjalmarson, Å., Goldstein, S., Fagerberg, B., Wedel, H., Waagstein, F., Kjekshus, J., Wikstrand, J., El Allaf, D., Vítovec, J., Aldershvile, J., et al. (2000) · JAMA · doi:10.1001/jama.283.10.1295 · Cited by 1,399
Troughton, R. W., Frampton, C. M., Yandle, T. G., Espine, E. A., Nicholls, M. G., & Richards, A. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02060-2 · Cited by 1,376
Plasma brain natriuretic peptide concentration: impact of age and gender
Redfield, M. M., Rodeheffer, R. J., Jacobsen, S. J., Mahoney, D. W., Bailey, K. R., & Burnett, J. C. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02059-4 · Cited by 1,138
Pfisterer, M., Buser, P., Rickli, H., Gutmann, M., Erne, P., Rickenbacher, P., Vuillomenet, A., Jeker, U., Dubach, P., Beer, H., et al. (2009) · JAMA · doi:10.1001/jama.2009.2 · Cited by 652
Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure
Jourdain, P., Jondeau, G., Funck, F., Gueffet, P., Le Helloco, A., Donal, E., Aupetit, J. F., Aumont, M. C., Galinier, M., Eicher, J. C., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.081 · Cited by 646
COPD as a Disease of Accelerated Lung Aging
Ito, K., & Barnes, P. J. (2009) · Chest · doi:10.1378/chest.08-1419 · Cited by 629
Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995
Haldeman, G. A., Croft, J. B., Giles, W. H., & Rashidee, A. (1999) · American Heart Journal · doi:10.1053/hj.1999.v137.95495 · Cited by 490
Does blinding of readers affect the results of meta-analyses?
Berlin, J. A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62352-5 · Cited by 478
Impact of age and sex on plasma natriuretic peptide levels in healthy adults
Wang, T. J., Larson, M. G., Levy, D., Leip, E. P., Benjamin, E. J., Wilson, P. W. F., Sutherland, P., Omland, T., & Vasan, R. S. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02464-5 · Cited by 471
Harrison, A., Morrison, L. K., Krishnaswamy, P., Kazanegra, R., Clopton, P., Dao, Q., Hlavin, P., & Maisel, A. S. (2002) · Annals of Emergency Medicine · doi:10.1067/mem.2002.121483 · Cited by 372
Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01116-0 · Cited by 363
Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials
Felker, G. M., Hasselblad, V., Hernandez, A. F., & O'Connor, C. M. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.06.018 · Cited by 334
Latini, R., Masson, S., Anand, I., Judd, D., Maggioni, A. P., Chiang, Y.-T., Bevilacqua, M., Salio, M., Cardano, P., Dunselman, P. H. J. M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000036747.68104.ac · Cited by 291
Murdoch, D. R., McDonagh, T. A., Byrne, J., Blue, L., Farmer, R., Morton, J. J., & Dargie, H. J. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70079-7 · Cited by 235
High- versus low-dose ACE inhibition in chronic heart failure
van Veldhuisen, D. J., Genth‐Zotz, S., Brouwer, J., Boomsma, F., Netzer, T., Veld, A. J. M. I. '., Pinto, Y. M., Lie, K. I., & Crijns, H. J. G. M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00464-1 · Cited by 133
Kawai, K., Hata, K., Takaoka, H., Kawai, H., & Yokoyama, M. (2001) · American Heart Journal · doi:10.1067/mhj.2001.115435 · Cited by 91
Worster, A., Balion, C. M., Hill, S., Santaguida, P. L., Ismaila, A., McKelvie, R. S., Reichert, S. M., McQueen, M., Booker, L., & Raina, P. S. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.08.008 · Cited by 89
Lainchbury, J. G., Troughton, R. W., FRAMPTON, C. M. A., Yandle, T. G., Hamid, A., Nicholls, M. G., & Richards, M. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.04.004 · Cited by 78
Cancer, aging and immunotherapy: lessons learned from animal models
Lustgarten, J. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0677-8 · Cited by 59
de Groote, P., Isnard, R., Clerson, P., Jondeau, G., Galinier, M., Assyag, P., Demil, N., Ducardonnet, A., Thébaut, J.-F., & Michel Komajda, N. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn005 · Cited by 58
Beck‐da‐Silva, L., de Bold, A., Fraser, M., Williams, K., & Haddad, H. A. (2005) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2005.04239.x · Cited by 49
Valle, R., Aspromonte, N., Carbonieri, E., DʼEri, A., Feola, M., Giovinazzo, P., Noventa, F., Prevaldi, C., Barro, S., & Milani, L. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.03.097 · Cited by 40
Characteristics of liver diseases in the elderly: a review.
Premoli, A., Paschetta, E., Hvalryg, M., Spandre, M., Bo, S., & Durazzo, M. (2009) · PubMed · Cited by 33
Brain natriuretic peptide and optimal management of heart failure
Li, N., & Wang, J.-A. (2005) · Journal of Zhejiang University. Science A · doi:10.1631/jzus.2005.b0877 · Cited by 30
Mant, D., Hobbs, R. F., Glasziou, P., Wright, L., Hare, R., Perera, R., Price, C., & Cowie, M. (2008) · British Journal of General Practice · doi:10.3399/bjgp08x299209 · Cited by 11
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Metadata
- Authors
- Porapakkham, P.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2010-03-22
- Volume
- 170
- Issue
- 6
- Pages
- 507
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2077678288
- Cited by
- 319
- References
- 31
- FWCI
- 28.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.